PHARMACYTE BIOTECH, INC. (PMCB) Total assets 2017–2026
PHARMACYTE BIOTECH, INC. (PMCB) total assets at each fiscal year-end, per SEC filings.
$46.8MFY2026 · since FY2017: $8.7M → $46.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $46.8M | -15.3% |
| FY2025 | $55.2M | -7.9% |
| FY2024 | $59.9M | -18.3% |
| FY2023 | $73.3M | -19.1% |
| FY2022 | $90.6M | +1124.0% |
| FY2021 | $7.4M | +20.1% |
| FY2020 | $6.2M | +6.6% |
| FY2019 | $5.8M | -9.8% |
| FY2018 | $6.4M | -26.0% |
| FY2017 | $8.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PMCB financial trends
PMCB RevenuePMCB Net incomePMCB Net marginPMCB Gross profitPMCB Gross marginPMCB Operating incomePMCB Operating marginPMCB Operating cash flowPMCB Free cash flowPMCB Capital expendituresPMCB Return on equityPMCB Stock buybacksPMCB Dividends paidPMCB Total liabilitiesPMCB Shareholders’ equityPMCB overview →